SENIOR MARKETING EXECUTIVE •Strategic, innovative, award-winning commercial executive with more than 19 years experience in product management, multi-channel marketing and strategic planning within healthcare. •Conceptualizes, develops, and executes inventive, well targeted strategies that positively impact market share, build brands and deliver revenue. Consistently introduce “first of its kind” marketing programs to transform customer relationships. •Creative catalyst, able to sell business plans and marketing opportunities with passion and purpose to garner executive support. •Transformational Leader that effectively builds, aligns and mentors highly productive and efficient teams through motivation and strategic leadership. •Trusted advisor to top executives. Quickly generates multiple alternatives to circumvent obstacles. Ability to make highly consequential decisions with only partial information.
2002 - Present
Recruited for role by US President.Strategic and operational leadership of $9B US commercial structure including sales force of 3000 and more than 18 pharmaceutical brands, 5 of which are greater than $1B. Member of US Management Team. Selected by Wyeth Board for Global Leadership Program-only top 1% of employees attend.
-Led 5 year strategic planning process with US Management Team to evolve the commercial structure to be more customer focused, drive revenue growth and reduce operating expenses.Identified initiatives to deliver an additional $1B in revenue for four key launch/pre-launch brands: Prevenar 13V Adult and Pediatric (Vaccines) , Pristiq (Depression) , and Bapineuzumab (Alzheimer’s).
-Drove creation of an Executive Leadership Advisory Board to expand relationships with US thought leaders to successfully reposition Wyeth as a partner on critical US healthcare system issues. Members include notable leaders from: CMS, CVS/Caremark, United Healthcare, Harvard, Yale, Towers Perrin, Medicare, Cigna, Goodyear, FDA.
-Established e-Prescribing Team with SureScripts, Aetna and Humana to understand key customer drivers.
-Initiated move from activity based metrics to performance based metrics to enhance decision making and focus commercial performance on goals that drive business. Instituted regular review of key brand performance metrics and goals at monthly US management team meetings for high value brands including Enbrel, Effexor XR, Protonix, Premarin family, Pristiq and Xyntha.
2009 - Present
Executive Director, Marketing
P&L management of $1.2B women’s healthcare product family. Create and champion a strategic vision for 9 marketing team members.Lead team to effectively leverage customer insights and provide distinctive value to three customer segments: payers, patients, and providers. Successfully align and integrate marketing strategies and tactics to grow the brands working within a cross functional team of sales, medical, regulatory, market research, public relations and other groups. $29M budget.
-Motivate and inspire team to establish actionable brand strategy leading to 6% market share growth and sales up 14% YOY.
-Enhanced integration with sales and sales leadership to meet brand detailing and sampling goals through improved training program, simplified messaging and targeting.
-Developed and monitor brand metrics that allow team to quickly make decisions that drive business performance.
-Lead the strategic marketing planning process across 3 brands to develop 2010 marketing plans to meet revenue goals.